Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Blood Rev. 2021 Mar 16;49:100825. doi: 10.1016/j.blre.2021.100825

Table 3.

Molecular formulas, half-lives and dosing schedules for BCR-ABL1 TKIs.

TKI Structural Formula Half Life Recommended Starting Dose
Imatinib graphic file with name nihms-1686883-t0004.jpg 18 hours 400 mg daily
Dasatinib graphic file with name nihms-1686883-t0005.jpg 3–5 hours 100 mg once daily
Nilotinib graphic file with name nihms-1686883-t0006.jpg 17 hours 300 mg twice daily
Ponatinib graphic file with name nihms-1686883-t0007.jpg 12–66 hours 45 mg once daily
Bosutinib graphic file with name nihms-1686883-t0008.jpg 22 hours (oral) 400 mg once daily
Asciminib graphic file with name nihms-1686883-t0009.jpg 8 hours 40 mg BID (estimated)